Soleno Therapeutics (SLNO) is back on traders’ screens after Wolfe Research kicked off coverage with an upbeat view, helping push the stock up about 5% as investors reassess the risk reward setup. See ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO) is among the cheap healthcare stocks to buy heading into 2026. As of December 7, ...

Supreme Group has launched Supreme Communications, a full-service PR and communications agency, by combining subsidiary agencies Amendola Communications and Health+Commerce. The 2025 MM+M Agency 100 ...

Detailed price information for Spyre Therapeutics Inc (SYRE-Q) from The Globe and Mail including charting and trades.

Soleno Therapeutics (NASDAQ:SLNO) drives innovation in rare disease treatments, often discussed within the Nasdaq index.

Detailed price information for Soleno Therapeutics Inc (SLNO-Q) from The Globe and Mail including charting and trades.

SAN DIEGO, Dec. 15, 2025 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether Soleno Therapeutics, Inc. (NASDAQ: SLNO) or certain of its officers and directors ...

Connecticut-based fund Braidwell bought nearly 1.3 million shares in Soleno Therapeutics during the third quarter. As a ...

Soleno Therapeutics, Inc. (NASDAQ:SLNO) ranks among the most oversold biotech stocks to invest in. Soleno Therapeutics, Inc. (NASDAQ:SLNO) reported third-quarter adjusted earnings of $0.47 per share ...

LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Soleno Therapeutics, Inc., (“Soleno" or the "Company") (NASDAQ: SLNO) investors that the firm has initiated an investigation ...

REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare ...

SAN FRANCISCO, Nov. 7, 2025 /PRNewswire/ -- On November 5, 2025, investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) saw the price of their shares tumble $18.78 (-28%) after the company reported ...